ReleaseWire Connect

Travelport, a leading provider of critical transaction processing solutions and data to companies operating in the global travel industry, and American Airlines, a wholly owned subsidiary of AMR Corporation (OTCQB: AAMRQ), announced a new long-term, global distribution agreement.

Oracle Corporation (NASDAQ: ORCL) traded in the range of $35.35 and $35.81 during its latest trading session. The stock had opened at $35.75 and is at $35.62, up 0.52 percent from its previous close of $35.43, with 11.368 million shares volume. Oracle Corporation’s MACD chart shows bullish trend. The stock may go as high as $35.96 level in the coming trading sessions. Its first support level is at $35.47. The company commands market capitalization of 168.56 billion.

Nvidia Corporation (NASDAQ: NVDA) traded in the range of $12.62 and $12.96 during its latest trading session. The stock had opened at $12.74 and is at $12.90, up 1.26 percent from its previous close of $12.74. Nvidia Corporation recorded the volume of 5.224 million shares. Its average daily trading volume stands at 10.713 million shares. Its MACD chart shows bullish trend and the stock may go as high as $13.09 in the coming sessions. Its first support level stands at $12.75, breaching this level, the stock may tumble to $12.68.

The Blackstone Group LP (NYSE: BX) stock is at $20.31, up 1.55 percent from its previous close of $20.00. The stock shows bullish trend as it made the up move with trading volume of 4.386 million shares, in contrast to the average daily trading volume of 5.01 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading higher than its 6 days EMA. The stock may go as high as $20.55 in its coming trading sessions.

Micron Technology Inc. (NASDAQ: MU) opened at $9.36 and oscillated in the range of $9.35 and $9.60 in the latest trading session. It is at $9.52, up 2.20 percent from its previous close of $9.32. Micron Technology shows bullish trend and the stock’s first resistance level is at $9.78. Upon breaching this level, the stock may touch $9.95. On the downside, it may slip to $9.35.

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shows bullish trend as the stock made a sharp movement in its latest trading session. It opened the session at $1.95 and remained in $1.92 and $2.00 price range during the session. The stock is 2.59 percent higher at $1.98. Chelsea Therapeutics’ first support level is at $1.95. Upon breaching this level, the stock may go as low as $1.89. On the upside, its first resistance level is at $2.03.

American Graphite Technologies Inc. (OTCQB: AGIN) stock is at $1.02, down 1.92 percent from its previous close of $1.04. However, its today’s volume of 685k shares is higher than its usual trading volume of 57k shares. The stock opened the session at $1.05 and touched its highest price point at $1.08. American Graphite Technologies’ lowest price point for the session stood at $0.96. The stock’s MACD chart shows neutral trend in the short term. Its first support level is at $0.98. Upon breaching this level, the stock may fall to $0.95 level.

Graphon Corporation (OTCQB: GOJO) is trading in the range of $0.45 and $0.55 in its current trading session. The stock recorded the volume of 2.69 million shares so far, in comparison its average daily trading volume of 135k shares. The stock opened at $0.45 and is currently at $0.48, up 17.07 percent from its previous close. Graphon Corporation has its first resistance level at $0.50 while it faces the support at $0.45. If the stock breaches this level, it may go touch $0.43.

Nestl (OTC Pink: NSRGY) announced its outlook for FY2013 last month, it expects organic growth between 5% and 6% together with an improved trading operating profit margin and underlying earnings per share in constant currency, as well as improvement in our capital efficiency.

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the initiation of a randomized, open label Phase 2 clinical study of Ad-RTS IL-12 in combination with palifosfamide to treat patients with non-resectable recurrent or metastatic breast cancer.